𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effect of melperone, chlorpromazine, haloperidol, and diazepam on experimental anxiety in normal subjects

✍ Scribed by Lars Molander

Publisher
Springer
Year
1982
Tongue
English
Weight
541 KB
Volume
77
Category
Article
ISSN
0033-3158

No coin nor oath required. For personal study only.

✦ Synopsis

An attempt was made to evaluate tranquilizing effects of three neuroleptic drugs (10 and 50 mg melperone, 1 mg haloperidol, and 50 mg chlorpromazine) and diazepam (10 mg) on experimental anxiety in normal subjects. This was done by studying the effects of the drugs on the anticipatory autonomic (skin conductance) response evoked during aversive classical conditioning. Diazepam, 50 mg melperone, and chlorpromazine completely abolished the anticipatory response, decreased the number of conditioned and unconditioned responses, and decreased skin conductance level. Treatment with 10 mg melperone and haloperidol had no effect on the conditioned and unconditioned responses.

πŸ“œ SIMILAR VOLUMES

A dose response study of the hypnotic ef
A dose response study of the hypnotic effectiveness of alprazolam and diazepam in normal subjects
✍ Michael H. Bonnet; Milton Kramer; Thomas Roth πŸ“‚ Article πŸ“… 1981 πŸ› Springer 🌐 English βš– 454 KB

One group of eight normal young males was administered three doses of alprazolam (0.25, 0.5 and 1.0 mg) and placebo, while a second group of eight normal young males was given three doses of diazepam (2, 5, and 10 rag) and placebo in the same design. All subjects slept in the sleep laboratory for i0

The effect of salbutamol on mood in norm
The effect of salbutamol on mood in normal subjects
✍ Dr David B. Menkes; J. Paul Fawcett; Megan R. Nunn; David Boothman-Burrell πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 353 KB πŸ‘ 1 views

## Abstract The beta‐2‐adrenoceptor agonist salbutamol, widely used in the treatment of asthma, is thought to have antidepressant activity and possibly an abuse liability. In order to examine the mood‐altering potential of this drug, a placebocontrolled, double‐blind crossover trial was conducted i